Literature DB >> 30239849

Can Less Be More for Individuals With Low-Risk Breast Cancer?

Kathy J Helzlsouer1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30239849      PMCID： PMC6658853          DOI： 10.1093/jnci/djy129

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Authors:  Carolyn Taylor; Candace Correa; Frances K Duane; Marianne C Aznar; Stewart J Anderson; Jonas Bergh; David Dodwell; Marianne Ewertz; Richard Gray; Reshma Jagsi; Lori Pierce; Kathleen I Pritchard; Sandra Swain; Zhe Wang; Yaochen Wang; Tim Whelan; Richard Peto; Paul McGale
Journal:  J Clin Oncol       Date:  2017-03-20       Impact factor: 44.544

2.  Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.

Authors:  Jinani Jayasekera; Clyde B Schechter; Joseph A Sparano; Reshma Jagsi; Julia White; Judith-Anne W Chapman; Timothy Whelan; Stewart J Anderson; Anthony W Fyles; Willi Sauerbrei; Richard C Zellars; Yisheng Li; Juhee Song; Xuelin Huang; Thomas B Julian; George Luta; Donald A Berry; Eric J Feuer; Jeanne Mandelblatt
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

3.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

4.  Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.

Authors:  B Fisher; R G Ravdin; R K Ausman; N H Slack; G E Moore; R J Noer
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

5.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

6.  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Matthew P Goetz; John A Olson; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Peter M Ravdin; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; Jeffrey L Berenberg; Jeffrey Abrams; George W Sledge
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

7.  Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.

Authors:  Jinani Jayasekera; Yisheng Li; Clyde B Schechter; Reshma Jagsi; Juhee Song; Julia White; George Luta; Judith-Anne W Chapman; Eric J Feuer; Richard C Zellars; Natasha Stout; Thomas B Julian; Timothy Whelan; Xuelin Huang; E Shelley Hwang; Judith O Hopkins; Joseph A Sparano; Stewart J Anderson; Anthony W Fyles; Robert Gray; Willi Sauerbrei; Jeanne Mandelblatt; Donald A Berry
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

Review 8.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.